Related references
Note: Only part of the references are listed.Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus
Jiaxi Xu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)
Impact of home confinement during COVID-19 pandemic on sleep parameters in Parkinson's disease
Niraj Kumar et al.
SLEEP MEDICINE (2021)
Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra
Ana I. Rodriguez-Perez et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Jacques Fantini et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Takeshi Moriguchi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
Rita Marreiros et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19
Serge Nataf
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review
Ali Sepehrinezhad et al.
JOURNAL OF NEUROVIROLOGY (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk
Nadine Kabbani et al.
MOLECULAR PHARMACOLOGY (2020)
Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID-19 Pandemic
Ali Shalash et al.
MOVEMENT DISORDERS (2020)
Effects ofCOVID-19 on Parkinson's Disease Clinical Features: ACommunity-Based Case-ControlStudy
Roberto Cilia et al.
MOVEMENT DISORDERS (2020)
Outcome of Parkinson's Disease Patients Affected by COVID-19
Angelo Antonini et al.
MOVEMENT DISORDERS (2020)
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy
Tommaso Schirinzi et al.
NEUROLOGICAL SCIENCES (2020)
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
Joy D. Iroegbu et al.
NEUROLOGICAL SCIENCES (2020)
Rapid worsening in Parkinson's disease may hide COVID-19 infection
Elodie Hainque et al.
PARKINSONISM & RELATED DISORDERS (2020)
Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse
Luiz G. Gardinassi et al.
FRONTIERS IN IMMUNOLOGY (2020)
RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus
Kevin E. Wu et al.
CELL SYSTEMS (2020)
Infectivity of human coronavirus in the brain
Qi Cheng et al.
EBIOMEDICINE (2020)
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
Peter Riederer et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy
Alfonso Fasano et al.
MOVEMENT DISORDERS (2020)
SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
Matija Fenrich et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
A case of probable Parkinson's disease after SARS-CoV-2 infection
Mikhal E. Cohen et al.
LANCET NEUROLOGY (2020)
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection
Lingli Zhou et al.
OCULAR SURFACE (2020)
Is COVID-19 a Perfect Storm for Parkinson's Disease?
Patrik Brundin et al.
TRENDS IN NEUROSCIENCES (2020)
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
David Sulzer et al.
NPJ PARKINSONS DISEASE (2020)
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
Ke Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease
Shweta Prasad et al.
NEUROLOGY INDIA (2020)
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience
Alfonso Fasano et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson's Disease
Roongroj Bhidayasiri et al.
JOURNAL OF MOVEMENT DISORDERS (2020)
Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease A Phase 2 Randomized Clinical Trial
Margaret Schenkman et al.
JAMA NEUROLOGY (2018)
Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm
J. William Langston et al.
NPJ PARKINSONS DISEASE (2018)
Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database
Gary McLean et al.
BMC NEUROLOGY (2017)
Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain
Erica L. Beatman et al.
JOURNAL OF VIROLOGY (2016)
Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
Lisa Fellner et al.
GLIA (2013)
Neuromelanin is an immune stimulator for dendritic cells in vitro
Uwe Oberlaender et al.
BMC NEUROSCIENCE (2011)
Viral parkinsonism
Haeman Jang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease
Belen Joglar et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
Haeman Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of human monocytes after infection by human coronavirus 229E
Marc Desforges et al.
VIRUS RESEARCH (2007)
Where does Parkinson disease pathology begin in the brain?
K Del Tredici et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Neuronal damage of the substantia nigra in HIV-1 infected brains
K Itoh et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
